Effects of rosiglitazone and pioglitazone on lipoprotein metabolism in patients with Type 2 diabetes and normal lipids.

Brackenridge, A L, Jackson, N, Jefferson, W, Stolinski, M, Shojaee-Moradie, F, Hovorka, R, Umpleby, A M and Russell-Jones, D (2009) Effects of rosiglitazone and pioglitazone on lipoprotein metabolism in patients with Type 2 diabetes and normal lipids. Diabetic Medicine, 26(5), pp. 532-539. ISSN (print) 0742-3071

Abstract

In patients with Type 2 diabetes and normal lipids, treatment with rosiglitazone or pioglitazone had no significant effect on lipoprotein metabolism compared with placebo.

Actions (Repository Editors)

Item Control Page Item Control Page